Related references
Note: Only part of the references are listed.Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy
Danique Beijer et al.
BRAIN (2019)
Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy
Steffen Syrbe et al.
BRAIN (2017)
Cytoskeletal Integrators: The Spectrin Superfamily
Ronald K. H. Liem
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Cell organization, growth, and neural and cardiac development require αII-spectrin
Michael C. Stankewich et al.
JOURNAL OF CELL SCIENCE (2011)
Dominant-Negative Mutations in α-II Spectrin Cause West Syndrome with Severe Cerebral Hypomyelination, Spastic Quadriplegia, and Developmental Delay
Hirotomo Saitsu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
A mutant αII-spectrin designed to resist calpain and caspase cleavage questions the functional importance of this process in vivo
Fleur Meary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sequential degradation of αII and βII spectrin by calpain in glutamate or maitotoxin-stimulated cells
Susan B. Glantz et al.
BIOCHEMISTRY (2007)
Structure of the calmodulin αII-spectrin complex provides insight into the regulation of cell plasticity
Miljan Simonovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
SH3 domain of spectrin participates in the. activation of Rac in specialized calpain-induced integrin signaling complexes
K Bialkowska et al.
JOURNAL OF CELL SCIENCE (2005)
Critical calpain-dependent ultrastructural alterations underlie the transformation of an axonal segment into a growth cone after axotomy of cultured Aplysia neurons
ME Spira et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
C-src binds αII spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr1176
JH Nedrelow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states
PW Vanderklish et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2000)